US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

317.20

+12.294.03%

Post-market: 317.870.6700+0.21%19:58 EDT

Volume:468.50K

Turnover:149.84M

Market Cap:689.75M

PE:- -

High:329.20

Open:311.70

Low:306.27

Close:304.91

52wk High:341.93

52wk Low:66.60

Shares:2.17M

Float Shares:2.17M

Volume Ratio:0.98

T/O Rate:21.55%

Dividend:1.02

Dividend Rate:0.32%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Guangdong Kanghua Healthcare Schedules Board Meeting on Interim Results and Dividend

Health Care Roundup: Market Talk

Nationwide Healthcare Security Blueprint for the 15th Five-Year Plan: Accelerating the Growth of Commercial Medical Insurance

Foundation Healthcare Well-Placed to Capture Shift to Lower-Cost Outpatient Care

Does FDA-Backed Mpox mRNA Trial and AstraZeneca Tie-Up Recast the Bull Case For CSPC (SEHK:1093)?

Simply Wall St.

MedSci Healthcare Sets August Board Meeting to Approve Interim Results and Dividend Plan

Promisia Healthcare Corrects Warrant Count After Capital Change

ASX Midday Sector Update: Healthcare Stocks Jump, Information Technology Sector Struggles

MT Newswires Live

Trump Taps Dr. Heidi Overton to Lead FDA

Xspray Pharma Gets FDA Complete Response Letter on Dasynoc, Speeds Manufacturing for 2026 Resubmission

Analysts Offer Insights on Healthcare Companies: Cogstate Ltd (OtherCOGZF), Pro Medicus Limited (OtherPMCUF) and Cochlear (OtherCHEOF)

ETF Daily | AAOZ Soars 30%; CBRZ Surges 25%; SOXS Jumps 15%; FNG Plunges 39%; Optical Communications Volatility Leads

Novartis’ iptacopan granted FDA orphan designation

Health Care up on Defensive Bias - Health Care Roundup

Health Care Roundup: Market Talk

Replimune Group Lawsuit Focuses on FDA Disclosure Issues and Sharp REPL Stock Drop

Analyst Reaffirms Buy Rating on Unicycive, Maintaining 12-Month Price Target at $30 After FDA Procedural Setback

Health Care Roundup: Market Talk

Argenx's Vyvgart Hytrulo Likely to Get FDA Approval for Myositis, RBC Says

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), Insight Molecular Diagnostics (IMDX) and Innovent Biologics (OtherIVBXF)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/LABU/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":317.2,"timestamp":1787342400000,"preClose":304.91,"halted":0,"volume":468504,"hourTrading":{"tag":"盘后","latestPrice":317.87,"preClose":317.2,"latestTime":"19:58 EDT","volume":6645,"amount":2111082.7734,"timestamp":1787356729854,"change":0.67,"changeRate":0.002112,"amplitude":0.006526},"delay":0,"changeRate":0.04030697582893301,"floatShares":2174486,"shares":2174486,"eps":0,"marketStatus":"Market Closed","change":12.29,"latestTime":"08-21 16:00:00 EDT","open":311.7,"high":329.2026,"low":306.27,"amount":149839169.98896,"amplitude":0.075211,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":304.91,"sharesOutstanding":3074486,"nav":316.946,"aum":673347221.03,"dividendRate":0.00323,"bidAskSpread":0.002803,"preHourTrading":{"tag":"盘前","latestPrice":313.6,"preClose":304.91,"latestTime":"09:27 EDT","volume":3793,"amount":1185778.2804,"timestamp":1787318868980,"change":8.69,"changeRate":0.0285,"amplitude":0.022236},"postHourTrading":{"tag":"盘后","latestPrice":317.87,"preClose":317.2,"latestTime":"19:58 EDT","volume":6645,"amount":2111082.7734,"timestamp":1787356729854,"change":0.67,"changeRate":0.002112,"amplitude":0.006526},"volumeRatio":0.9815516107169615,"impliedVol":0.9442,"impliedVolPercentile":0.6693},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2174486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9815516107169615,"shares":2174486,"dividePrice":1.0247,"high":329.2026,"amplitude":0.075211,"preClose":304.91,"low":306.27,"week52Low":66.6,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":317.2,"eps":0,"divideRate":0.00323,"volume":468504,"delay":0,"ttmEps":0,"open":311.7,"prevYearClose":159.39,"prevWeekClose":276.54,"prevMonthClose":227.4,"prevQuarterClose":292.1,"fiveDayClose":276.54,"twentyDayClose":245.6,"sixtyDayClose":186},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660445442","title":"Guangdong Kanghua Healthcare Schedules Board Meeting on Interim Results and Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2660445442","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660445442?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:39","pubTimestamp":1787128742,"startTime":"0","endTime":"0","summary":"The latest update is out from Guangdong Kanghua Healthcare Co., Ltd. Class H ( ($HK:3689) ). Guangdong Kanghua Healthcare Group has scheduled a boa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/guangdong-kanghua-healthcare-schedules-board-meeting-on-interim-results-and-dividend?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/guangdong-kanghua-healthcare-schedules-board-meeting-on-interim-results-and-dividend?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","LU0029874061.USD","HCSG","LU0128526141.USD","BK4581","BK4585","BK4137","XBI","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660437324","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2660437324","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660437324?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:20","pubTimestamp":1787127600,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0722 GMT - Foundation Healthcare looks well-placed to capture th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","XBI","BK4588","BK4585","BK4581","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103533631","title":"Nationwide Healthcare Security Blueprint for the 15th Five-Year Plan: Accelerating the Growth of Commercial Medical Insurance","url":"https://stock-news.laohu8.com/highlight/detail?id=1103533631","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103533631?lang=en_us&edition=fundamental","pubTime":"2026-08-19 15:42","pubTimestamp":1787125345,"startTime":"0","endTime":"0","summary":"The National Healthcare Security Administration issued the \"Nationwide Healthcare Security Blueprint for the 15th Five-Year Plan\" on August 19, outlining a strong push to advance commercial medical...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XLV","XBI","LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660001410","title":"Foundation Healthcare Well-Placed to Capture Shift to Lower-Cost Outpatient Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2660001410","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660001410?lang=en_us&edition=fundamental","pubTime":"2026-08-19 15:22","pubTimestamp":1787124120,"startTime":"0","endTime":"0","summary":"0722 GMT - Foundation Healthcare looks well-placed to capture the shift from inpatient care to lower-cost outpatient care, OCBC Group Research's Troy Cheng says in a research report. Its healthcare ecosystem, which comprises specialist practices, medical centers, and its proprietary 'AVA' technology platform, addresses inefficiencies in private specialist care, the analyst says. Foundation Healthcare's ownership of four medical centers allows it to capture facility and diagnostic revenues while enhancing control over patients' recovery path. The company is one of Singapore's largest and fastest-growing multi-specialty specialist platforms. OCBC initiates coverage of the stock with a buy rating and a fair value estimate of 1.13 Singapore dollars. Shares are 1.3% lower at S$0.755.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XBI","FHH.SI","LU0029874061.USD","LU0128526141.USD","HCSG","XLV","BK4137","BK6100","BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660480614","title":"Does FDA-Backed Mpox mRNA Trial and AstraZeneca Tie-Up Recast the Bull Case For CSPC (SEHK:1093)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660480614","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660480614?lang=en_us&edition=fundamental","pubTime":"2026-08-19 13:12","pubTimestamp":1787116367,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group recently reported three developments: U.S. FDA approval to begin clinical trials for its mpox mRNA vaccine, a US$10,000,000 milestone payment from AstraZeneca tied to their small-molecule collaboration, and a joint venture with AstraZeneca to build a biologics manufacturing facility in Shijiazhuang, China.\nTogether, these moves expand CSPC’s innovative vaccine and drug pipeline while pushing its manufacturing and quality systems further onto the global stage.\nWe’ll...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1093/cspc-pharmaceutical-group-shares/news/does-fda-backed-mpox-mrna-trial-and-astrazeneca-tie-up-recas","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1093/cspc-pharmaceutical-group-shares/news/does-fda-backed-mpox-mrna-trial-and-astrazeneca-tie-up-recas","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BZ08YS42.EUR","LU1960683339.HKD","LU2039709279.SGD","BK4588","LU0326950275.SGD","LU1807302812.USD","BK1515","LU0314109678.HKD","01093","IE00BZ08YR35.GBP","LU1152091168.USD","IE0008368742.USD","LU0880133367.SGD","LU1993786604.SGD","IE00B5MMRT66.SGD","BK1191","LU0315179316.USD","IE00BZ08YT58.USD","LU1226287529.USD","LU1226287792.SGD","LU1226287875.USD","IE00B031HY20.USD","LABU","KURE","BK4585","LU0072913022.USD","BK1521","LU1008478684.HKD","LU0140636845.USD","SG9999004220.SGD","LU1226288170.HKD","IE0008369823.USD","LU1813983027.USD","LU1226288253.USD","LU1328277881.USD","LU0501845795.SGD","LU0067412154.USD","LU1152091754.HKD","IE00B543WZ88.USD","LU1951186391.HKD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660414855","title":"MedSci Healthcare Sets August Board Meeting to Approve Interim Results and Dividend Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2660414855","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660414855?lang=en_us&edition=fundamental","pubTime":"2026-08-19 12:38","pubTimestamp":1787114313,"startTime":"0","endTime":"0","summary":"An update from MedSci Healthcare Holdings Limited ( ($HK:2415) ) is now available. MedSci Healthcare Holdings Limited has scheduled a board meeting...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/medsci-healthcare-sets-august-board-meeting-to-approve-interim-results-and-dividend-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/medsci-healthcare-sets-august-board-meeting-to-approve-interim-results-and-dividend-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU0029874061.USD","BK4588","XLV","HCSG","XBI","BK4137","LU0128526141.USD","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660411317","title":"Promisia Healthcare Corrects Warrant Count After Capital Change","url":"https://stock-news.laohu8.com/highlight/detail?id=2660411317","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660411317?lang=en_us&edition=fundamental","pubTime":"2026-08-19 11:17","pubTimestamp":1787109450,"startTime":"0","endTime":"0","summary":"The latest update is out from Promisia Healthcare Limited ( ($NZ:PHL) ). Promisia Healthcare Limited has corrected an earlier capital change notice...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/promisia-healthcare-corrects-warrant-count-after-capital-change?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/promisia-healthcare-corrects-warrant-count-after-capital-change?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4581","XLV","HCSG","LU0128526141.USD","LU0029874061.USD","BK4585","BK4137","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660419637","title":"ASX Midday Sector Update: Healthcare Stocks Jump, Information Technology Sector Struggles","url":"https://stock-news.laohu8.com/highlight/detail?id=2660419637","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660419637?lang=en_us&edition=fundamental","pubTime":"2026-08-19 10:52","pubTimestamp":1787107958,"startTime":"0","endTime":"0","summary":"Healthcare stocks advanced nearly 2% at midday Wednesday.CSL (ASX:CSL) gained almost 4% in recent trade.On the flip side, the information technology sector struggled, shedding almost 5%.Wisetech Global (ASX:WTC) shares fell nearly 13% in recent trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["III","BK7067","BK7511","XBI","BK4134","BK4581","BK4137","BK7016","XLV","LU0128526141.USD","BK7508","WTC.AU","BK4585","LU0029874061.USD","BK4588","BK7501","CSL.AU","HCSG","BK7503","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660415031","title":"Trump Taps Dr. Heidi Overton to Lead FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2660415031","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660415031?lang=en_us&edition=fundamental","pubTime":"2026-08-19 09:43","pubTimestamp":1787103780,"startTime":"0","endTime":"0","summary":"President Trump has selected one of his top White House health aides, Dr. Heidi Overton, as his next choice to lead the Food and Drug Administration, people familiar with the matter said.Overton, who ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","DBB","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660720415","title":"Xspray Pharma Gets FDA Complete Response Letter on Dasynoc, Speeds Manufacturing for 2026 Resubmission","url":"https://stock-news.laohu8.com/highlight/detail?id=2660720415","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660720415?lang=en_us&edition=fundamental","pubTime":"2026-08-19 09:32","pubTimestamp":1787103146,"startTime":"0","endTime":"0","summary":"Xspray Pharma AB ( ($SE:XSPRAY) ) has shared an update. Xspray Pharma has received a Complete Response Letter from the FDA for its lead oncology ca...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xspray-pharma-gets-fda-complete-response-letter-on-dasynoc-speeds-manufacturing-for-2026-resubmission?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xspray-pharma-gets-fda-complete-response-letter-on-dasynoc-speeds-manufacturing-for-2026-resubmission?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4554","LABU","LU0348788117.USD","LU2177674079.SGD","FDNI","LU0737861269.HKD","SG9999006266.SGD","BK4581","BK4588","LU0345776255.USD","LU0572940350.SGD","LU1048588211.SGD","SG9999002406.SGD","SG9999013486.USD","SGXZ58947870.SGD","IE0001KFT4U8.USD","LU0532188223.SGD","BK4585","LU0345775950.USD","LU0823039010.USD","LU0441851309.USD","LU0264606111.USD","LU0499858438.USD","LU2125910500.SGD","LU2065169927.USD","BK4085","LU2543165471.USD","SG9999002414.USD","BK4548","LU0175139822.USD","SE","LU0261945553.USD","LU0516422440.USD","LU0979878070.USD","SG9999002620.SGD","IE0031814969.USD","SG9999014492.USD","SG9999001135.SGD","SG9999014484.SGD","LU0499858602.USD","IE0034224299.USD","LU2152927971.USD","LU0516422366.SGD","LU0516423174.USD","LU2065171402.SGD","SG9999004360.SGD","LU2065171311.SGD","LU0516423091.SGD","LU0289960550.SGD","LU1242518857.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660415929","title":"Analysts Offer Insights on Healthcare Companies: Cogstate Ltd (OtherCOGZF), Pro Medicus Limited (OtherPMCUF) and Cochlear (OtherCHEOF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660415929","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660415929?lang=en_us&edition=fundamental","pubTime":"2026-08-19 09:10","pubTimestamp":1787101805,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cogstate Ltd (COGZF), Pro Medicus Limited (PMCUF) and Cochlear (C...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cogstate-ltd-othercogzf-pro-medicus-limited-otherpmcuf-and-cochlear-othercheof-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cogstate-ltd-othercogzf-pro-medicus-limited-otherpmcuf-and-cochlear-othercheof-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4137","BK4167","HCSG","XBI","XLV","PMCUF","BK4588","COGZF","LU0128526141.USD","BK4581","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134001578","title":"ETF Daily | AAOZ Soars 30%; CBRZ Surges 25%; SOXS Jumps 15%; FNG Plunges 39%; Optical Communications Volatility Leads","url":"https://stock-news.laohu8.com/highlight/detail?id=1134001578","media":"ETF Tracker","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134001578?lang=en_us&edition=fundamental","pubTime":"2026-08-19 08:40","pubTimestamp":1787100000,"startTime":"0","endTime":"0","summary":"Market OverviewOn Tuesday Aug 18, the Dow Jones Industrial Average dipped 0.22%, the S&P 500 fell 0.69%, and the Nasdaq Composite dropped 1.33%.ETF trading skewed defensive, with inverse and bear...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"e426da9b0703426f963fa150b0854bd3","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IEI","IE00BGHQF748.EUR","LU2543165471.USD","CRWV","SSO","DULL","BK4020","IE00B66KJ199.SGD","BK4563","DGP","GLDY","CBRS","VTWO","CBRZ","SG9999014005.SGD","SPUU","LU0289961442.SGD","KEEX","SMH","LU0205193047.USD","IE0031619046.USD","CHPY","LU2125910500.SGD","HIBL","LU0205194284.USD","TLTI","URTY","IWM","AAOZ","CORD","IAUI","USD","FNG","AAOI","LU1861559042.SGD","LYTE","IAU","BK7104","LITX","SPY","DMAX","DUST","FLGV","TBJL","SG9999014021.USD","BAR","USG","GLDM","IE00BKPKM429.USD","SMHX","BK4112","SGOV","SOXS","FTXL","BK7142","RWM","AGQ","LU0106261612.USD","SPTL","YGLD","LU0012050646.USD","SHY","LU0289739343.SGD","LCLG","AAAU","GLL","UGL","SSG","TNA","LU2095319765.USD","BWZ","FDN","BWX","CRWG","LU2294711713.HKD","IE00BQXX3D17.EUR","VCLT","LU0240878834.USD","LU0511384066.AUD","SIVR","LU2249611893.SGD","LUMA","SOXL","IVV","LITZ","SPXU","LU2210149790.SGD","LU1861215975.USD","GLD","BBSB","IE00BQXX3F31.USD","IE00BQXX3C00.GBP","IE00BN0W2W23.USD","IE00B64PRP62.GBP","SPIP","CHPS","SHNY","BEX","SG9999014013.SGD","BBIB","SPYH","LU1861558580.USD","BBLB","SOXX","BK4585","KGLD","LU0823414551.USD","LU0240877869.USD","LABU","LU2360107168.USD","TIP","BEG","IGLD","IGOV","YSPY","LU0823414478.USD","LU2045819591.USD","BEZ","XSD","OUNZ","SOXQ","SGOL","BK4570","ZSL","IEF","BK4147","TLH","FOTO","BK4116","SPXS","LU2506951792.HKD","LU0314104364.USD","ISHG","DIG","SPYU","UWM","CRWU","SHV","SPYQ","BCDF","XBI","ERX","TSYW","KEEL","QQQX","TLT","DZZ","EGGY","FN","TFJL","XLE","BK4145","LU1861220033.SGD","TWM","SPXL","LIAO","SG9999014039.USD","CWVX","BK4550","TLTX","SPDN","TEKX","LU2357125470.USD","TZA","SH","LU2290526834.HKD","XLV","PSI","SLV","BK4588","IE00BN0W2V16.EUR","LAZR","IE00B3QW5Z07.USD","AAOG","LITE","BGLD","LU2210150020.SGD","VOO","DGZ","BK4593","IAUM","SMAX","MMAX","TLTW","UPRO","XITK","LITG","SDS","SPYM","AAOX","FGDL","LVIG","BK7062","BK4581","UNG","AEHG","CWII","IE00B7SZL793.SGD","IE00BN0W2T93.GBP","IE00B19Z4B17.USD","SOXY","LU0348723411.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660902804","title":"Novartis’ iptacopan granted FDA orphan designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2660902804","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660902804?lang=en_us&edition=fundamental","pubTime":"2026-08-19 07:00","pubTimestamp":1787094013,"startTime":"0","endTime":"0","summary":"Novartis (NVS)’ iptacopan was granted FDA orphan designation as a treatment of atypical hemolytic uremic syndrome, according to a post to the agenc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-iptacopan-granted-fda-orphan-designation-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-iptacopan-granted-fda-orphan-designation-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PPH","BK4007","BK4532","IE0002141913.USD","IE00B2B36J28.USD","LU0208291251.USD","LU0320765489.SGD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","BK4585","MEDX","BK4588","BK4578","LU0070302665.USD","NVS","IE0009355771.USD","LABU","IE00BJT1NW94.SGD","LU0211331839.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660749731","title":"Health Care up on Defensive Bias - Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2660749731","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660749731?lang=en_us&edition=fundamental","pubTime":"2026-08-19 05:11","pubTimestamp":1787087460,"startTime":"0","endTime":"0","summary":"Health-care companies rallied as traders rotated into a defensive sector that's less sensitive to inflation and interest-rate moves.Shares of obesity drug maker Eli Lilly rose by more than 3% to test all-time highs. Health-care conglomerate Johnson & Johnson also tested record highs.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN8TJ469.HKD","LU2468319806.SGD","LU0792757196.USD","LU1221951129.SGD","IYH","IE00BLSP4452.SGD","LU2213496289.HKD","LABU","FHLC","IHE","LU1162221912.USD","LU2129689605.HKD","LU2487616109.SGD","LU0820561818.USD","LU2417539215.USD","IE00BZ1G4Q59.USD","IE00BVYPNW00.USD","GDOC","LU2505996509.AUD","LU2750360997.AUD","MEDX","BK4550","LU1059921491.USD","IE00B4R5TH58.HKD","LU0203347892.USD","LU1244550577.SGD","LU0889566641.SGD","JNJ","LU0124676726.USD","LU1066051811.HKD","PJP","IE00BJJMRZ35.SGD","LU2023250330.USD","FTXH","RXL","SG9999001176.SGD","IE00BFXG1179.USD","IXJ","LU1043141396.HKD","LU1261432733.SGD","IE00B2B36J28.USD","LU1074936037.SGD","TRUH","XBI","XLV","JDOC","IE00BGHQF631.EUR","LU0072461881.USD","VHT","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660549224","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2660549224","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660549224?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:50","pubTimestamp":1787086200,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0311 ET - Ipca Laboratories' earnings growth momentum looks stro","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LABU","BK4588","XLV","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660494146","title":"Replimune Group Lawsuit Focuses on FDA Disclosure Issues and Sharp REPL Stock Drop","url":"https://stock-news.laohu8.com/highlight/detail?id=2660494146","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660494146?lang=en_us&edition=fundamental","pubTime":"2026-08-19 03:29","pubTimestamp":1787081359,"startTime":"0","endTime":"0","summary":"Replimune Group, Inc. (NASDAQ: REPL) is facing a federal securities lawsuit alleging that investors were not told key facts about regulatory weakne...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/replimune-group-lawsuit-focuses-on-fda-disclosure-issues-and-sharp-repl-stock-drop?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/replimune-group-lawsuit-focuses-on-fda-disclosure-issues-and-sharp-repl-stock-drop?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GPIQ","QLD","QQQM","QQQJ","BK4585","QYLG","BK4139","QQQY","LABU","QQQE","TQQY","QDTE","ONEQ","BK4588","PSQ","NDX","QQQ","SQQQ","NQmain","REPL",".IXIC","TECS","TQQQ","MNQmain","JEPQ","NVIW.SI","QQQA","IYW","FTEC","QID"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660449966","title":"Analyst Reaffirms Buy Rating on Unicycive, Maintaining 12-Month Price Target at $30 After FDA Procedural Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2660449966","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660449966?lang=en_us&edition=fundamental","pubTime":"2026-08-19 01:05","pubTimestamp":1787072720,"startTime":"0","endTime":"0","summary":"Analyst Jason McCarthy from Maxim Group maintained a Buy rating on Unicycive Therapeutics and keeping the price target at $30.00. Jason McCarthy ha...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-reaffirms-buy-rating-on-unicycive-maintaining-12-month-price-target-at-30-after-fda-procedural-setback-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-reaffirms-buy-rating-on-unicycive-maintaining-12-month-price-target-at-30-after-fda-procedural-setback-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660496155","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2660496155","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660496155?lang=en_us&edition=fundamental","pubTime":"2026-08-19 00:20","pubTimestamp":1787070000,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0311 ET - Ipca Laboratories' earnings growth momentum looks stro","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4581","BK4585","BK4588","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660495503","title":"Argenx's Vyvgart Hytrulo Likely to Get FDA Approval for Myositis, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660495503","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660495503?lang=en_us&edition=fundamental","pubTime":"2026-08-18 23:06","pubTimestamp":1787065592,"startTime":"0","endTime":"0","summary":"Argenx's (ARGX) Vyvgart Hytrulo is likely to get approval from the US Food and Drug Administration for adults with immune-mediated necrotizing myopathy and dermatomyositis, RBC Capital Markets analyst","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1983260115.SGD","IE0009355771.USD","LABU","LU0889565916.HKD","BK4505","FMED","BK4588","IE00BFTCPJ56.SGD","LU0109394709.USD","IE00BJT1NW94.SGD","LU0823416689.USD","IBB","LU0320765992.SGD","IE00B2B36J28.USD","TBXU","IE0034235188.USD","ARGX","BK4139","IE0002141913.USD","LU2324357040.USD","BK4585","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660493221","title":"Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), Insight Molecular Diagnostics (IMDX) and Innovent Biologics (OtherIVBXF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660493221","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660493221?lang=en_us&edition=fundamental","pubTime":"2026-08-18 22:40","pubTimestamp":1787064009,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amylyx Pharmaceuticals Inc (AMLX), Insight Molecular...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amylyx-pharmaceuticals-inc-amlx-insight-molecular-diagnostics-imdx-and-innovent-biologics-otherivbxf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amylyx-pharmaceuticals-inc-amlx-insight-molecular-diagnostics-imdx-and-innovent-biologics-otherivbxf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4137","HCSG","IMDX","XLV","LABU","BK4139","BK4588","BK4585","XBI","AMLX","BK4007","BK4581","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":6,"totalSize":387,"code":"91000000","status":"200"}]}}